Larvol Delta - BioPath-Announces-Patient-Dosing-in-Amended-Phase-2-Prexigebersen-Trial-in-Acute-Myeloid-Leukemia

decitabine - Generic Mfg.

Venclexta (venetoclax) - Roche, AbbVie

prexigebersen (BP1001) - Bio-path

http://www.globenewswire.com/news-release/2019/08/26/1906379/0/en/Bio-Path-Announces-Patient-Dosing-in-Amended-Phase-2-Prexigebersen-Trial-in-Acute-Myeloid-Leukemia.html

Aug 26, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next